The global cosmetic industry valued at $450 billion in 2025 isn’t just expanding.Read More

The biotech and pharma industries are evolving at breakneck speed. But most professionals still lump them together—missing the nuances that define their risks, opportunities, and strategic decisions.Read More

What do Paracetamol, Metformin, and Amoxicillin have in common? They’re among the most consumed active pharmaceutical ingredients (APIs) in the worldRead More

Get a snapshot of Atorvastatin’s global DMF filings, certification types, and sourcing insights using publicly available Chemxpert data. Atorvastatin isn’t new. But it still dominates.Read More

Global drug pricing isn’t just a policy issue—it’s a business-critical variable that affects every player in the pharmaceutical value chain. FromRead More

Biosimilars are near-identical versions of approved biologics, offering similar safety, efficacy, and quality—but at a lower cost. Unlike generics, biosimilars are made from living cells and require complex development and regulatory approval.Read More

The pharmaceutical industry plays a critical role in advancing global health, enabling innovation in drug development, and ensuring access to life-saving treatments across populations.Read More

Ever had a breakthrough idea—only to be stalled by a compound that doesn’t exist yet?Read More

The global active pharmaceutical ingredients industry is estimated to be worth $232.13 billion in 2025. By 2030, this figure is expected to reach $328.94 billion at a CAGR of 7.22%.Read More

A little history teaches us that the pharmaceutical industry has always been in a state of evolution due to rapid changes in technology, health consumer demands, and immediate needs in global health matters.Read More